Submit Release

EIN Presswire is celebrating 30 years! Follow us on Substack for customer insights, interviews, and more!

World Media Directory · RSS · Email Newsletters

There were 2,112 press releases posted in the last 24 hours and 438,080 in the last 365 days.

Press Releases on July 22, 2023

203 Press Releases

Published on July 22, 2023 - 00:13 GMT

Hemlo Explorers Announces Closing of Final Tranche of Non-Brokered Private Placement

TORONTO, July 21, 2023 (GLOBE NEWSWIRE) -- Hemlo Explorers Inc. (the “Company”) (TSXV: HMLO) is pleased to announce that it has closed the second and final tranche of its previously announced non-brokered private placement (the “Offering”). In the final …

Distribution channels: Mining Industry ...
Published on July 22, 2023 - 00:12 GMT

Governor Newsom Issues Legislative Update 7.21.23

Published: Jul 21, 2023 SACRAMENTO – Governor Gavin Newsom today announced that he has signed the following bills: AB 72 by Assemblymember Tasha Boerner (D-Encinitas) – Coastal resources: research: landslides and erosion: early warning system. AB 87 by …

Distribution channels:
Published on July 22, 2023 - 00:09 GMT

Governor Newsom Issues Legislative Update 7.21.23

Published: Jul 21, 2023 SACRAMENTO – Governor Gavin Newsom today announced that he has signed the following bills: AB 72 by Assemblymember Tasha Boerner (D-Encinitas) – Coastal resources: research: landslides and erosion: early warning system. AB 87 by …

Distribution channels:
Published on July 22, 2023 - 00:01 GMT

Summary of opinion: Enrylaze,crisantaspase, 20/07/2023, Positive

On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Enrylaze, intended for the treatment of acute lymphoblastic leukaemia ( …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:01 GMT

Summary of opinion: Ervebo,Ebola Zaire Vaccine (rVSV∆G-ZEBOV-GP, live), 20/07/2023, Positive

Summary of opinion: Ervebo,Ebola Zaire Vaccine (rVSV∆G-ZEBOV-GP, live), 20/07/2023, Positive

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:01 GMT

Summary of opinion: Tyenne,tocilizumab, 20/07/2023, Positive

On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Tyenne, intended for the treatment of rheumatoid arthritis (RA), …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:01 GMT

Summary of opinion: Yesafili,aflibercept, 20/07/2023, Positive

On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Yesafili, intended for the treatment of neovascular (wet) age-related …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:01 GMT

Summary of opinion: Bylvay,odevixibat, 20/07/2023, Positive

On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Bylvay. The marketing authorisation holder for this medicinal …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:01 GMT

Summary of opinion: Keytruda,pembrolizumab, 20/07/2023, Positive

On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Keytruda. The marketing authorisation holder for this …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:01 GMT

Summary of opinion: Krazati,adagrasib, 20/07/2023, Negative

The European Medicines Agency has recommended the refusal of the conditional marketing authorisation for Krazati, a medicine intended for treating advanced non-small cell lung cancer (NSCLC) with KRAS G12C mutation. The Agency issued its opinion on 20 July …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:01 GMT

Summary of opinion: Talvey,talquetamab, 20/07/2023, Positive

On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a conditional1 marketing authorisation for the medicinal product Talvey2, intended for the treatment of multiple myeloma. …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:01 GMT

Summary of opinion: Olumiant,baricitinib, 20/07/2023, Positive

On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Olumiant to include the treatment of juvenile idiopathic …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:01 GMT

Summary of opinion: Inaqovi,cedazuridine,decitabine, 20/07/2023, Positive

On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Inaqovi, intended for the treatment of acute myeloid leukaemia (AML). …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:01 GMT

Summary of opinion: Spikevax (previously COVID-19 Vaccine Moderna),elasomeran,imelasomeran and elasomeran,davesomeran and ...

On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Spikevax. The marketing authorisation holder for this …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:01 GMT

Summary of opinion: Tepkinly,epcoritamab, 20/07/2023, Positive

On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a conditional1 marketing authorisation for the medicinal product Tepkinly2, intended for the treatment of diffuse large B‑ …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:01 GMT

Summary of opinion: Opdivo,nivolumab, 20/07/2023, Positive

On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Opdivo. The marketing authorisation holder for this medicinal …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:00 GMT

Summary of opinion: Tevimbra,tislelizumab, 20/07/2023, Positive

On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Tevimbra1 intended for the treatment of oesophageal squamous cell …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:00 GMT

Summary of opinion: Abrysvo,Respiratory syncytial virus vaccines, 20/07/2023, Positive

On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Abrysvo, intended for the prevention of lower respiratory tract (LRT) …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:00 GMT

Summary of opinion: Apretude,cabotegravir, 20/07/2023, Positive

On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Apretude, intended for prevention of sexually acquired HIV-1 in …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on July 22, 2023 - 00:00 GMT

Summary of opinion: Degarelix Accord,degarelix acetate, 20/07/2023, Positive

On 20 July 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Degarelix Accord, intended for the treatment of hormone dependent …

Distribution channels: Healthcare & Pharmaceuticals Industry

Previous 1 2 3 4 5 6 7 8 9 10 11 Next

Previous Day 2023 Calendar Next Day